These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 17965467)
21. EEG Pattern in Neonatal Maple Syrup Urine Disease: Description and Clinical Significance. Poothrikovil RP; Al Thihli K; Al Futaisi A Neurodiagn J; 2021 Sep; 61(3):123-131. PubMed ID: 34449278 [TBL] [Abstract][Full Text] [Related]
22. Maple Syrup Urine Disease Complicated with Kyphoscoliosis and Myelopathy. Hou JW Pediatr Neonatol; 2016 Oct; 57(5):431-435. PubMed ID: 24486081 [TBL] [Abstract][Full Text] [Related]
23. Management of acute decompensation of neonatal maple syrup urine disease with continuous arteriovenous haemofiltration: report of one case. Lin MC; Chen CH; Fu LS; Jan SL; Shu SG; Chi CS Acta Paediatr Taiwan; 2002; 43(5):281-4. PubMed ID: 12607485 [TBL] [Abstract][Full Text] [Related]
24. A case of maple syrup urine disease misdiagnosed as tetanus neonatorum on admission. Kültürsay N; Kütükçüler N; Büyükgebiz B; Kleijer WJ Acta Paediatr Jpn; 1994 Jun; 36(3):284-6. PubMed ID: 8091979 [TBL] [Abstract][Full Text] [Related]
25. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine. Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005 [TBL] [Abstract][Full Text] [Related]
26. [3 patients with maple syrup urine disease]. Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657 [TBL] [Abstract][Full Text] [Related]
27. Treatment of maple syrup urine disease with high flow hemodialysis in a neonate. Aygün F; Kıykım E; Aktuğlu-Zeybek Ç; Zubarioğlu T; Cam H Turk J Pediatr; 2019; 61(1):107-110. PubMed ID: 31559730 [TBL] [Abstract][Full Text] [Related]
28. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation. Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664 [TBL] [Abstract][Full Text] [Related]
29. [Peritoneal dialysis in a neonate with maple syrup urine disease. A case report]. Ramírez F; Mato I; Barboza A; Cejas Bestard N Arch Argent Pediatr; 2020 Apr; 118(2):e178-e182. PubMed ID: 32199060 [TBL] [Abstract][Full Text] [Related]
30. [Maple syrup urine disease of neonates: report of two cases and review of literature]. Chen Z; Luo F; Wu XJ; Shi LP Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):680-4. PubMed ID: 21092528 [TBL] [Abstract][Full Text] [Related]
31. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease. McMahon Y; MacDonnell RC Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835 [TBL] [Abstract][Full Text] [Related]
32. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125 [TBL] [Abstract][Full Text] [Related]
33. Oxidative stress in plasma from maple syrup urine disease patients during treatment. Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828 [TBL] [Abstract][Full Text] [Related]
34. Early diagnosis of maple syrup urine disease using polymerase chain reaction-based mutation detection. Silao CL; Padilla CD; Matsuo M Pediatr Int; 2008 Jun; 50(3):312-4. PubMed ID: 18533943 [TBL] [Abstract][Full Text] [Related]
35. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis. Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198 [TBL] [Abstract][Full Text] [Related]
36. Typical neuroradiological diagnosis of maple syrup urine disease as a precursor to clinical diagnosis. A case report. Srinivasan KG; Ramprabananth S; Ushanandhini KP; Srividya S Neuroradiol J; 2009 Dec; 22(5):564-7. PubMed ID: 24209402 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease. Terek D; Koroglu O; Yalaz M; Gokben S; Calli C; Coker M; Kultursay N Neuropediatrics; 2013 Aug; 44(4):208-12. PubMed ID: 23341096 [TBL] [Abstract][Full Text] [Related]
38. M aple syrup urine disease. A review with a report of an additional case. Schwartz JF; Kolendrianos ET Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351 [No Abstract] [Full Text] [Related]
39. Clues and challenges in the diagnosis of intermittent maple syrup urine disease. Pode-Shakked N; Korman SH; Pode-Shakked B; Landau Y; Kneller K; Abraham S; Shaag A; Ulanovsky I; Daas S; Saraf-Levy T; Reznik-Wolf H; Vivante A; Pras E; Almashanu S; Anikster Y Eur J Med Genet; 2020 Jun; 63(6):103901. PubMed ID: 32151765 [TBL] [Abstract][Full Text] [Related]
40. Living related versus deceased donor liver transplantation for maple syrup urine disease. Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]